Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Mini Pulse Dexamethasone in Pediatric Vitiligo
Sponsor: Cairo University
Summary
The goal of this clinical trial is to learn if oral mini pulse (OMP) dexamethasone works to treat active vitiligo in children and also learn about the safety of this drug within this age group the main questions it aims to answer are does OMP halt activity in active vitiligo and what medical problems patients might experience while using the drug with special attention to linear growth. Researchers will give OMP dexamethasone to participating patients to see if the drug works to treat active vitiligo and whether it has any effect on linear growth. Participants will take OMP dexamethasone two fixed days per week for a period of 3 months. before starting treatment, patients will do baseline evaluation and investigations then monthly evaluation to monitor progress, report any side effects at the end of treatment period response to drug, lab values and growth will be evaluated then final evaluation of growth will be done after stoppage of drug.
Official title: The Efficacy and Safety of Oral Mini-pulse Dexamethasone in Active Non-segmental Vitiligo Within the Pediatric Age Group
Key Details
Gender
All
Age Range
4 Years - 9 Years
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2026-02-28
Completion Date
2026-07
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
Dexamethasone (0.1 mg/kg)
patients will receive oral mini pulse dexamethasone 2 fixed consecutive days per week in a dose of 0.1mg/kg/day for a period of 3 months
Locations (1)
Dermatology Outpatient Clinic, Kasr al Ainy Teaching Hospital, Cairo University
Cairo, Egypt